Skip to content

Pilot Study for Speculum Free Cervical Cancer Screening

A Pilot Study Continuation to Assess the Use of an Introducer "Calla" During Cervical Cancer Screening

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04107181
Acronym
Calla
Enrollment
305
Registered
2019-09-27
Start date
2016-04-14
Completion date
2028-02-01
Last updated
2026-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical Cancer

Keywords

Pap smear

Brief summary

The objective of the work described in this protocol is to determine the optical signatures of cervical dysplasia using optical technologies.

Detailed description

This project is to assess if the introducer, "calla", can be used in place of a speculum during a routine Pap smear. For the patient arm, the introducer will be used in conjunction with standard of care procedures. The healthy volunteer arm will include taking the introducer home for a week to determine if each person can find their cervix without the help of a physician. As well as completing surveys on ease of use and demographics related to their medial history.

Interventions

DEVICEIntroducer "calla" device

The research introducer will be used after the patient consents prior to the annual pap smear.

BEHAVIORALInterviews only

Healthy volunteer interviews

Sponsors

Duke University
Lead SponsorOTHER
Korle-Bu Teaching Hospital, Accra, Ghana
CollaboratorOTHER
National Cancer Institute (NCI)
CollaboratorNIH

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SCREENING
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
21 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

Healthy female * Aged 21-65 years * Have had a pelvic exam * Have conversational proficiency in English * Highest level of education attained

Exclusion criteria

\- Pregnant women

Design outcomes

Primary

MeasureTime frameDescription
Assessment of introducerUp to 1 week (at time of pap smear for patients and up to 1 week for healthy volunteers)We will conduct interviews/surveys to determine if subjects enrolled prefer introducer over SOC speculum

Countries

United States

Contacts

CONTACTNimmi Ramanujam, PhD
nimmi@duke.edu9196605307
CONTACTJennifer Gallagher, BA
jennifer.gallagher@duke.edu9199701551
PRINCIPAL_INVESTIGATORNimmi Ramanujam, PhD

Duke

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 7, 2026